Literature DB >> 10421557

Acute cellular alterations in the hippocampus after status epilepticus.

R L Macdonald1, J Kapur.   

Abstract

The critical, fundamental mechanisms that determine the emergence of status epilepticus from a single seizure and the prolonged duration of status epilepticus are uncertain. However, several general concepts of the pathophysiology of status epilepticus have emerged: (a) the hippocampus is consistently activated during status epilepticus; (b) loss of GABA-mediated inhibitory synaptic transmission in the hippocampus is critical for emergence of status epilepticus; and, finally (c) glutamatergic excitatory synaptic transmission is important in sustaining status epilepticus. This review focuses on the alteration of GABAergic inhibition in the hippocampus that occurs during the prolonged seizures of status epilepticus. If reduction in GABAergic inhibition leads to development of status epilepticus, enhancement of GABAergic inhibition would be expected to interrupt status epilepticus. Benzodiazepines and barbiturates are both used in the treatment of status epilepticus and both drugs enhance GABA(A) receptor-mediated inhibition. However, patients often become refractory to benzodiazepines when seizures are prolonged, and barbiturates are often then used for these refractory cases of status epilepticus. Recent evidence suggests the presence of multiple GABA(A) receptor isoforms in the hippocampus with different sensitivity to benzodiazepines but similar sensitivity to barbiturates, thus explaining why the two drug classes might have different clinical effects. In addition, rapid functional plasticity of GABA(A) receptors has been demonstrated to occur during status epilepticus in rats. During status epilepticus, there was a substantial reduction of diazepam potency for termination of the seizures. The loss of sensitivity of the animals to diazepam during status epilepticus was accompanied by an alteration in the functional properties of hippocampal dentate granule cell GABA(A) receptors. Dentate granule cell GABA(A) receptor currents from rats undergoing status epilepticus had reduced sensitivity to diazepam and zinc but normal sensitivity to GABA and pentobarbital. Therefore, the prolonged seizures of status epilepticus rapidly altered the functional properties of hippocampal dentate granule cell GABA(A) receptors, possibly explaining why benzodiazepines and barbiturates may not be equally effective during treatment of the prolonged seizures of status epilepticus. A comprehensive understanding of the cellular and molecular events leading to the development, maintenance, and cytotoxicity of status epilepticus should permit development of more effective treatment strategies and reduction in the mortality and morbidity of status epilepticus.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10421557     DOI: 10.1111/j.1528-1157.1999.tb00873.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  12 in total

1.  New developments in antiepileptic drug resistance: an integrative view.

Authors:  Dieter Schmidt; Wolfgang Löscher
Journal:  Epilepsy Curr       Date:  2009 Mar-Apr       Impact factor: 7.500

2.  Reduced excitatory drive onto interneurons in the dentate gyrus after status epilepticus.

Authors:  J Doherty; R Dingledine
Journal:  J Neurosci       Date:  2001-03-15       Impact factor: 6.167

Review 3.  Super-Refractory Status Epilepticus.

Authors:  Mauricio Ruiz Cuero; Panayiotis N Varelas
Journal:  Curr Neurol Neurosci Rep       Date:  2015-11       Impact factor: 5.081

Review 4.  Generalised convulsive status epilepticus: an overview.

Authors:  R Nandhagopal
Journal:  Postgrad Med J       Date:  2006-11       Impact factor: 2.401

5.  Development of pharmacoresistance to benzodiazepines but not cannabinoids in the hippocampal neuronal culture model of status epilepticus.

Authors:  Laxmikant S Deshpande; Robert E Blair; Nisha Nagarkatti; Sompong Sombati; Billy R Martin; Robert J DeLorenzo
Journal:  Exp Neurol       Date:  2007-01-09       Impact factor: 5.330

6.  MicroRNA expression profiles in chronic epilepsy rats and neuroprotection from seizures by targeting miR-344a.

Authors:  Xixia Liu; Yuhan Liao; Xiuxiu Wang; Donghua Zou; Chun Luo; Chongdong Jian; Yuan Wu
Journal:  Neuropsychiatr Dis Treat       Date:  2017-07-31       Impact factor: 2.570

7.  Prognostic factors of status epilepticus in children.

Authors:  Du Cheol Kang; Young-Mock Lee; JoonSoo Lee; Heung Dong Kim; ChangJun Coe
Journal:  Yonsei Med J       Date:  2005-02-28       Impact factor: 2.759

8.  Temporal lobe epilepsy in the elderly.

Authors:  L E Morillo
Journal:  Epilepsy Res Treat       Date:  2011-11-24

9.  Changes in Hippocampal Volume are Correlated with Cell Loss but Not with Seizure Frequency in Two Chronic Models of Temporal Lobe Epilepsy.

Authors:  Roberson S Polli; Jackeline M Malheiros; Renan Dos Santos; Clement Hamani; Beatriz M Longo; Alberto Tannús; Luiz E Mello; Luciene Covolan
Journal:  Front Neurol       Date:  2014-07-01       Impact factor: 4.003

10.  Anti-Epileptic Effects of FABP3 Ligand MF1 through the Benzodiazepine Recognition Site of the GABAA Receptor.

Authors:  Yasushi Yabuki; Jiaqi Liu; Ichiro Kawahata; Hisanao Izumi; Yasuharu Shinoda; Kohei Koga; Shinya Ueno; Norifumi Shioda; Kohji Fukunaga
Journal:  Int J Mol Sci       Date:  2020-08-01       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.